FSD Pharma Inc.(NASDAQ:HUGE) 
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological di...
Website: http://www.fsdpharma.com
Founded: 1998
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-02-15
P
O 0.83
H 0.86
L 0.83
C 0.84
V 25,132
10EMA 0.84
20EMA 0.84
60EMA 0.84
120EMA 0.84
250EMA 0.84